Superstring Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-68,892
Closed -$2.66M 46
2024
Q4
$2.66M Buy
+68,892
New +$2.66M 2.3% 13
2024
Q1
Sell
-379,143
Closed -$8.69M 43
2023
Q4
$8.69M Buy
+379,143
New +$8.69M 6.21% 6